logo
logo

Q Bio Raises $40 Million Series B Led by Andreessen Horowitz to Bring Preventative Health and the Physical of the Future to Masses

Feb 20, 2020•over 5 years ago

Amount Raised

$40 Million

Round Type

series b

San Carlos

Description

Q Bio, a quantitative, clinically-relevant assessment of personal human health, today announced it has officially come out of stealth mode and secured $40 million in Series B funding led by Andreessen Horowitz. This brings Q Bio’s total funding to $58 million. This latest round of funding will allow Q Bio to continue to improve its proprietary platform and technology to make their preventive health services faster, better and more affordable for all.

Company Information

Company

Q Bio

Location

San Carlos, California, United States

About

Founded in 2015 by serial entrepreneur Jeff Kaditz, Dr. Michael Snyder and Dr. Garry Choy, Q Bio gives you a deeper understanding of your body and how it’s changing, so you have more control over your health. Q Bio’s platform is a quantitative, clinically-relevant assessment of personal human health. We believe in making preventive health available to everyone so that treatable diseases no longer take lives.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech